China Regulatory Express: New Essential Medicines Include Anticancers, HCV Combo
Executive Summary
China has bolstered its reimbursement of important newer drugs for cancer and hepatitis C, offering full insurance coverage to six newer oncology products and a sofosbuvir combo through the latest update to its essential medicines list.